Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …

Objective Metabolic dysfunction-associated steatotic liver disease (MASLD) and
cardiometabolic conditions affect populations across economic strata. Nevertheless, there …

The consensus group, comprising patients from multiple societies, has updated the
terminology for non-alcoholic fatty liver disease (NAFLD) to “metabolic dysfunction …

As such modifications often yield considerable confusion from numerous perspectives, it is
likely that we will encounter obstacles for some time. In particular, in order to avoid wasting …

Obesity is associated with an increased risk for 13 different cancers. The increased risk for
cancer in obesity is mediated by obesity-associated changes in the immune system. Obesity …

Abstract Background & Aims Alcohol-associated liver diseases (ALDs) and alcohol use
disorder (AUD) pose a global health risk. AUD is underrecognized in the elderly, and the …

Background Anthropometric indicators have been shown to be associated with the
prognosis of patients with cancer. However, any single anthropometric index has limitation …

Abstract Background and Aim Metabolic dysfunction‐associated steatotic liver disease
(MASLD) is associated with an increased risk of extrahepatic morbidity. We compared the …

Abstract Background and Objective Early-onset pancreatic cancer (EOPC) is associated with
poor prognosis and high disease burden. Metabolic risk factors such as diabetes and …

Le constat est sans équivoque: près de la moitié des décès par cancer pourraient être
évités! Cette affirmation, à la fois alarmante et porteuse d'espoir, souligne l'importance …